The University of Southampton
University of Southampton Institutional Repository

Overcoming barriers in the pharmacological treatment of anxiety disorders

Overcoming barriers in the pharmacological treatment of anxiety disorders
Overcoming barriers in the pharmacological treatment of anxiety disorders
Anxiety disorders are common, distressing and impairing medical conditions that typically have an early onset and prolonged course, are associated with substantial comorbidity and result in increased use of health services. A range of psychological and pharmacological treatments for patients with anxiety disorders are widely available, but many patients who would be likely to benefit from intervention do not seek medical attention, and others who do present are not recognized by their doctors as having a potentially treatable condition. The overall care of many patients with anxiety disorders who are recognized and treated falls markedly below generally recommended standards. This review explores the many barriers to optimal pharmacological treatment of patients with anxiety disorders and suggests methods by which these obstacles might be overcome.

1758-2008
33-44
Baldwin, D.S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Rafiq, R.
143c6a70-1466-4880-b0e9-e273c31b927e
Talat, B.
d21cd045-f7f7-4062-99dd-d11cc5d55823
Baldwin, D.S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Rafiq, R.
143c6a70-1466-4880-b0e9-e273c31b927e
Talat, B.
d21cd045-f7f7-4062-99dd-d11cc5d55823

Baldwin, D.S., Rafiq, R. and Talat, B. (2013) Overcoming barriers in the pharmacological treatment of anxiety disorders. Neuropsychiatry, 3 (1), 33-44. (doi:10.2217/npy.12.73).

Record type: Article

Abstract

Anxiety disorders are common, distressing and impairing medical conditions that typically have an early onset and prolonged course, are associated with substantial comorbidity and result in increased use of health services. A range of psychological and pharmacological treatments for patients with anxiety disorders are widely available, but many patients who would be likely to benefit from intervention do not seek medical attention, and others who do present are not recognized by their doctors as having a potentially treatable condition. The overall care of many patients with anxiety disorders who are recognized and treated falls markedly below generally recommended standards. This review explores the many barriers to optimal pharmacological treatment of patients with anxiety disorders and suggests methods by which these obstacles might be overcome.

Full text not available from this repository.

More information

Published date: 2013
Organisations: Faculty of Medicine

Identifiers

Local EPrints ID: 367931
URI: http://eprints.soton.ac.uk/id/eprint/367931
ISSN: 1758-2008
PURE UUID: 0c3054cb-034e-403a-9341-b25be8992515
ORCID for D.S. Baldwin: ORCID iD orcid.org/0000-0003-3343-0907

Catalogue record

Date deposited: 09 Sep 2014 12:52
Last modified: 18 Feb 2021 16:44

Export record

Altmetrics

Contributors

Author: D.S. Baldwin ORCID iD
Author: R. Rafiq
Author: B. Talat

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×